Keep up to date with the latest developments at CDISC and follow our news feeds!

CDISC invites you to an FDA-hosted public broadcast during the SEND Team’s fall virtual meetings. The broadcast is an opportunity for stakeholders to stay informed on what’s going on with the development of SEND and its use in regulatory submissions, as well as hear use cases from our global SEND user community.

METUCHEN, NJ and AUSTIN, TX – 24 May 2022 – Embleema Inc. and CDISC have announced a collaboration to develop new standards for experimental assays and bioinformatics protocols to facilitate monitoring the activity of Cell and Gene Therapy Products (CGTP).
Austin, TX – 27 Apr 2022 – CDISC today announced an expansion of its offerings with the official affiliation of volunteer-based Trial Master File (TMF) Reference Model Group. The combined organizations will operate under the CDISC brand and continue serving the clinical research community by providing resources that foster greater efficiencies across the industry ecosystem.
Austin, TX – 20 January 2022 – CDISC today announced three new members have joined its Board of Directors. Karen Curran, Brooke Hinkson, and Lisa Lin each began serving a three-year term at the beginning of the year.